Drugs becoming eligible for first Paragraph IV ANDA filing in 2031
Drugs expiring in 2032
Ohemo Life patents expiration
Duaklir Pressair patents expiration
Bicillin C-R 900/300 patents expiration
Astellas patents expiration
Boston Scitfc patents expiration
Aphelion patents expiration
